RDIA
GSK icon

RE Dickinson Investment Advisors’s GSK GSK Stock Holding History

RE Dickinson Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$200 Buy
+5
New +$180 ﹤0.01% 270

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RE Dickinson Investment Advisors's GSK Position: Q4 2024 in Review

RE Dickinson Investment Advisors opened a new position in GSK (GSK) in Q4 2024: 5 shares worth $200. The stake represents ﹤0.01% of the portfolio and ranks #270 among its holdings.

850 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • RE Dickinson Investment Advisors held 5 shares of GSK worth $200 as of Q4 2024.
  • GSK was a new RE Dickinson Investment Advisors position in Q4 2024.
  • GSK made up ﹤0.01% of RE Dickinson Investment Advisors's portfolio in Q4 2024, its #270 holding.
  • 850 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on RE Dickinson Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.